Anticoagulants

"Anticoagulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that prevent BLOOD CLOTTING.

Descriptor ID	D000925
MeSH Number(s)	D27.505.954.502.119
Concept/Terms	Anticoagulants Anticoagulants Anticoagulation Agents Agents, Anticoagulation Anticoagulant Agents Agents, Anticoagulant Anticoagulant Drugs Drugs, Anticoagulant Anticoagulant Indirect Thrombin Inhibitors Indirect Thrombin Inhibitors Inhibitors, Indirect Thrombin Thrombin Inhibitors, Indirect

Below are MeSH descriptors whose meaning is more general than "Anticoagulants".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Hematologic Agents [D27.505.954.502]
Anticoagulants [D27.505.954.502.119]

Below are MeSH descriptors whose meaning is related to "Anticoagulants".

Below are MeSH descriptors whose meaning is more specific than "Anticoagulants".

Anticoagulants
Antithrombins

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anticoagulants" by people in this website by year, and whether "Anticoagulants" was a major or minor topic of these publications.

Bar chart showing 85 publications over 25 distinct years, with a maximum of 7 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
1999	0	1	1
2001	0	1	1
2002	2	0	2
2003	2	2	4
2004	1	2	3
2005	1	0	1
2006	1	1	2
2007	1	0	1
2008	1	0	1
2009	4	2	6
2010	3	1	4
2011	2	1	3
2012	3	3	6
2013	3	1	4
2014	4	0	4
2015	5	0	5
2016	3	1	4
2017	4	0	4
2018	2	3	5
2019	2	2	4
2020	6	1	7
2021	1	3	4
2022	2	2	4
2023	0	4	4

Below are the most recent publications written about "Anticoagulants" by people in Profiles.

Dumas A, Goyal N, Mottamal M, Afosah DK, Al-Horani RA. Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors. J Thromb Thrombolysis. 2024 Dec; 57(8):1308-1314.

View in: PubMed
Rodr?guez-Fern?ndez K, Reynaldo-Fern?ndez G, Reyes-Gonz?lez S, de Las Barreras C, Rodr?guez-Vera L, Vlaar C, Monbaliu JM, Stelzer T, Duconge J, Mangas-Sanjuan V. New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model. Biomed Pharmacother. 2024 Jan; 170:115977.

View in: PubMed
Desai R, Mondal A, Prasad A, Vyas A, Jain A, Rupareliya C, Shah M, Paul T, Kumar G, Sachdeva R. Concurrent Cardio-Cerebral Infarctions in COVID-19: A Systematic Review of Published Case Reports/Series. Curr Probl Cardiol. 2023 Oct; 48(10):101814.

View in: PubMed
Lee HJ, Kim HK, Kim BS, Han KD, Park CS, Rhee TM, Park JB, Lee H, Kim YJ. Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment. Sci Rep. 2023 02 04; 13(1):2060.

View in: PubMed
Al-Horani RA, Afosah DK, Mottamal M. Triazol-1-yl Benzamides Promote Anticoagulant Activity via Inhibition of Factor XIIa. Cardiovasc Hematol Agents Med Chem. 2023; 21(2):108-119.

View in: PubMed
Steiner HE, Carrion KC, Giles JB, Lima AR, Yee K, Sun X, Cavallari LH, Perera MA, Duconge J, Karnes JH. Local Ancestry-Informed Candidate Pathway Analysis of Warfarin Stable Dose in Latino Populations. Clin Pharmacol Ther. 2023 03; 113(3):680-691.

View in: PubMed
Guo JS, He M, Gabriel N, Magnani JW, Kimmel SE, Gellad WF, Hernandez I. Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation. J Manag Care Spec Pharm. 2022 Dec; 28(12):1400-1409.

View in: PubMed
Al-Horani RA, Parsaeian E, Mohammad M, Mottamal M. Sulfonated non-saccharide molecules and human factor XIa: Enzyme inhibition and computational studies. Chem Biol Drug Des. 2022 07; 100(1):64-79.

View in: PubMed
Harris HM, Boyet KL, Liu H, Dwivedi R, Ashpole NM, Tandon R, Bidwell GL, Cheng Z, Fassero LA, Yu CS, Pomin VH, Mitra D, Harrison KA, Dahl E, Gurley BJ, Kotha AK, Chougule MB, Sharp JS. Safety and Pharmacokinetics of Intranasally Administered Heparin. Pharm Res. 2022 Mar; 39(3):541-551.

View in: PubMed
Afosah DK, Ofori E, Mottamal M, Al-Horani RA. Factor IX(a) inhibitors: an updated patent review (2003-present). Expert Opin Ther Pat. 2022 Apr; 32(4):381-400.

View in: PubMed

People

Explore

Similar Concepts

Top Journals